The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available in the world ...
Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling CareDx will ...
“Illumina’s…presentations and product descriptions revealed a workflow that infringed on the ‘607, ‘138, ‘505, and ‘487 patents, 10x Genomics and Prognosys Biosciences argued.” On October 21, 10x ...
Precision medicine company CareDx and 10x Genomics have partnered to launch ImmuneScape, a multiomics program to improve the understanding of transplant organ rejection and variability in patient ...
Key Points Interested in 10x Genomics? Here are five stocks we like better. Atera demand is strong ahead of launch: Booked ...
Imaging-based single-molecule spatial transcriptomics is dominated by three platforms: 10x Genomics' Xenium, the CosMx Spatial Molecular Imager (SMI), and MERSCOPE. Each images RNA transcripts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results